R. Alan B. Ezekowitz
Directeur/Membre du Conseil chez ORGANON & CO.
Fortune : 227 077 $ au 31/05/2024
Profil
R.
Alan B.
Ezekowitz is the founder of Azanta Danmark A (founded in 2000) and Abide Therapeutics, Inc. (founded in 2011).
He held the title of Chief Executive Officer & Director at Abide Therapeutics, Inc. in 2019.
Currently, Dr. Ezekowitz holds the position of Director-Scientific Advisory Board at Codman Co., Inc. He is also an Independent Director at Fulcrum Therapeutics, Inc. since 2016, an Independent Director at Organon & Co. since 2021, a Venture Partner at CHP Management, Inc., an Advisory Partner at Third Rock Ventures LLC since 2019, and a Member of the American Society of Clinical Investigation.
In the past, Dr. Ezekowitz served as Chairman-Scientific Advisory Board at Anika Therapeutics, Inc. He was a Non-Executive Director at Oxagen Ltd.
from 2013 to 2017.
He also held the position of Director at The Children's Hospital Corp., Director-Scientific Advisory Board at Entomed SA, and Director at Atopix Therapeutics Ltd.
Additionally, he was the Director & Chief-Pediatric Services at Mass General Brigham, Inc. from 1999 to 2006 and Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2006 to 2011.
He was a Principal at Massachusetts General Hospital Cancer Center and an Associate Professor at Harvard Medical School from 1995 to 2005.
In 2011, he founded Alan Ezekowitz LLC and held the title of Principal.
Dr. Ezekowitz obtained a doctorate degree from the University of Oxford and a graduate degree from the University of Cape Town in 1977.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
17/06/2024 | 28 927 ( 0,05% ) | 227 077 $ | 31/05/2024 | |
ORGANON & CO.
-.--% | 07/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de R. Alan B. Ezekowitz
Sociétés | Poste | Début |
---|---|---|
FULCRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2016 |
ORGANON & CO. | Directeur/Membre du Conseil | 02/06/2021 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | 01/12/2019 |
American Society of Clinical Investigation | Corporate Officer/Principal | - |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Private Equity Investor | 01/01/2011 |
Codman Co., Inc. | Directeur/Membre du Conseil | 20/08/2009 |
Anciens postes connus de R. Alan B. Ezekowitz
Sociétés | Poste | Fin |
---|---|---|
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Fondateur | 01/05/2019 |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 22/08/2017 |
Alan Ezekowitz LLC | Private Equity Investor | 02/11/2011 |
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de R. Alan B. Ezekowitz
University of Oxford | Doctorate Degree |
University of Cape Town | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ANIKA THERAPEUTICS, INC. | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
ORGANON & CO. | Health Technology |
Entreprise privées | 14 |
---|---|
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Health Technology |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Finance |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Entomed SA discovers and develops novel medicines derived from insects. It discovers and develops new drugs derived from the biology of insects with a focus on their immune response. Entomed's technology is based on the scientific work carried out by Prof. Jules A. Hoffmann's world leading team in the CNRS Institute of Molecular and Cellular Biology (IBMC) in Strasbourg. The company was founded in 1999 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Codman Co., Inc. | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Health Services |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Health Services |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
Atopix Therapeutics Ltd.
Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
American Society of Clinical Investigation | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
Alan Ezekowitz LLC | |
Mass General Brigham, Inc.
Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Health Services |